scispace - formally typeset
P

Pia Kvistborg

Researcher at Netherlands Cancer Institute

Publications -  76
Citations -  12753

Pia Kvistborg is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: T cell & Immunotherapy. The author has an hindex of 31, co-authored 71 publications receiving 9724 citations. Previous affiliations of Pia Kvistborg include Hebrew University of Jerusalem & Ludwig Institute for Cancer Research.

Papers
More filters
Journal ArticleDOI

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Naiyer A. Rizvi, +28 more
- 03 Apr 2015 - 
TL;DR: Treatment efficacy was associated with a higher number of mutations in the tumors, and a tumor-specific T cell response paralleled tumor regression in one patient, suggesting that the genomic landscape of lung cancers shapes response to anti–PD-1 therapy.
Journal ArticleDOI

Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma

Nienke van Rooij, +16 more
- 10 Nov 2013 - 
TL;DR: Cancer exome–guided analysis of T-cell reactivity in this patient revealed reactivity against two neoantigens, including a dominant T- cell response against a mutant epitope of the ATR (ataxia telangiectasia and Rad3 related) gene product that increased strongly after ipilimumab treatment.
Journal ArticleDOI

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

Andrea Cossarizza, +462 more
- 01 Oct 2019 - 
TL;DR: These guidelines are a consensus work of a considerable number of members of the immunology and flow cytometry community providing the theory and key practical aspects offlow cytometry enabling immunologists to avoid the common errors that often undermine immunological data.
Journal ArticleDOI

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Christian U. Blank, +23 more
- 08 Oct 2018 - 
TL;DR: It is found that neoadjuvant ipilimumab + nivolumab expand more tumor-resident T cell clones than adjuvant application, and warrants future evaluation with modified dosing schedules to reduce treatment-related adverse events.
Journal ArticleDOI

Guidelines for the use of flow cytometry and cell sorting in immunological studies

Andrea Cossarizza, +246 more
- 01 Oct 2017 - 
TL;DR: A rapid search in PubMed shows that using "flow cytometry immunology" as a search term yields more than 68 000 articles, the first of which is not about lymphocytes as mentioned in this paper.